Global $24.6 Billion Soft Tissue Repair Market Analysis &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global $24.6 Billion Soft Tissue Repair Market Analysis & Trends Report 2016-2025: Growing Expansions of Soft Tissue Repairs by Leading Players in Developing Countries

Dublin, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Soft Tissue Repair Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Soft Tissue Repair Market is poised to grow at a CAGR of around 8.3% over the next decade to reach approximately $24.6 billion by 2025.

This industry report analyzes the global markets for Soft Tissue Repair across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments Key Topics Covered: 1 Market Outline 1.1 Research Methodology 1.2 Market Trends 1.3 Regulatory Factors 1.4 Product Analysis 1.5 Application Analysis 1.6 Strategic Benchmarking 1.7 Opportunity Analysis 2 Executive Summary 3 Market Overview 3.1 Current Trends 3.1.1 Increasing Number of Investments for Soft Tissue Repair in Emerging Markets 3.1.2 Growing Expansions of Soft Tissue Repairs by Leading Players in Developing Countries 3.1.3 Rising Aging Population and Increasing Obesity Rate 3.1.4 Growth Opportunities/Investment Opportunities 3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness 4 Soft Tissue Repair Market, By Product 4.1 Laparoscopic Instruments 4.1.1 Laparoscopic Instruments Market Forecast to 2025 (US$ MN) 4.2 Fixation Products 4.2.1 Fixation Products Market Forecast to 2025 (US$ MN) 4.2.1.1 Screws 4.2.1.1.1 Screws Market Forecast to 2025 (US$ MN) 4.2.1.2 Pins 4.2.1.2.1 Pins Market Forecast to 2025 (US$ MN) 4.2.1.3 Anchors 4.2.1.3.1 Anchors Market Forecast to 2025 (US$ MN) 4.2.1.4 Sutures 4.2.1.4.1 Sutures Market Forecast to 2025 (US$ MN) 4.2.1.5 Matrix 4.2.1.5.1 Matrix Market Forecast to 2025 (US$ MN) 4.2.1.6 Implants 4.2.1.6.1 Implants Market Forecast to 2025 (US$ MN) 4.2.1.7 Patch 4.2.1.7.1 Patch Market Forecast to 2025 (US$ MN) 4.2.1.8 Grafts 4.2.1.8.1 Grafts Market Forecast to 2025 (US$ MN) 4.2.1.9 Other Fixation Products 4.2.1.9.1 Other Fixation Products Market Forecast to 2025 (US$ MN) 4.3 Tissue Patch/Mesh 4.3.1 Tissue Patch/Mesh Market Forecast to 2025 (US$ MN) 4.3.1.1 Biological Mesh 4.3.1.1.1 Biological Mesh Market Forecast to 2025 (US$ MN) 4.3.1.1.1.1 Xenograft 4.3.1.1.1.1.1 Xenograft Market Forecast to 2025 (US$ MN) 4.3.1.1.1.2 Allograft 4.3.1.1.1.2.1 Allograft Market Forecast to 2025 (US$ MN) 4.3.1.2 Synthetic Mesh 4.3.1.2.1 Synthetic Mesh Market Forecast to 2025 (US$ MN) 5 Soft Tissue Repair Market, By Application 5.1 Breast Reconstruction Repair 5.2 Orthopedic 5.3 Vaginal Sling Procedures 5.4 Hernia Repair 5.5 Dental 5.6 Skin Repair 5.7 Dural Repair 5.8 Anterior/Posterior Cruciate Ligament (ACL/PCL) Reconstruction 5.9 Cartilage Repair 5.10 Nerve Conduit 5.11 Rotator Cuff Repair 5.12 Shoulder Labrum Repair 5.13 Other Applications 6 Soft Tissue Repair Market, By Geography 7 Leading Companies 7.1 American Medical Systems Inc. 7.2 Integra Lifesciences Corporation 7.3 Arthrex, Inc. 7.4 Johnson & Johnson 7.5 Lifecell Corporation 7.6 Smith & Nephew PLC 7.7 Covidien PLC 7.8 Lifenet Health, Inc. 7.9 Wright Medical 7.10 C.R Bard, Inc. 7.11 Stryker Corporation 7.12 Organogenesis 7.13 Ethicon US 7.14 Medtronic plc 7.15 ArthroCare Corporation For more information about this report visit http://www.researchandmarkets.com/research/gq...lobal_soft

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Surgical Procedures

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for Block Investors This Spring

Updated Category News Views 119

Investigation By Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently looking into issues concerning Block, Inc. (NASDAQ: SQ). The firm is focusing on claims related to alleged violations of federal securities laws that may have resulted in significant losses for investors. If you have experienced a loss of over $75,000...

Continue Reading
Aviat Networks Faces Scrutiny After Annual Report Delay

Updated Category News Views 85

Investor Concerns Escalate Amid Aviat Networks' Delay in Reporting Aviat Networks, Inc. (NASDAQ: AVNW) is facing a tough situation as its stock price suffered a notable decline, falling by $6.36, or around 26%, during intraday trading on a recent date. This drop followed the company's announcement that it would miss the deadline for filing its financial statements for the...

Continue Reading
Tarsus Pharmaceuticals Prepares to Share Q2 2025 Results

Updated Category News Views 243

Anticipating Tarsus Pharmaceuticals' Financial Report Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to present its financial results for the second quarter of 2025 during a live webcast slated for Wednesday, August 6, 2025. This event will commence at 1:30 p.m. PT and 4:30 p.m. ET, providing a timely update on the company's performance and strategic...

Continue Reading
Country Garden's Stock Recovers After Debt Restructuring Efforts

Updated Category News Views 135

Country Garden’s Stock Trading Resumes with Momentum Recently, shares of Country Garden (HK: 2007), a prominent name in the Chinese property market, saw an impressive rise as trading resumed in Hong Kong after a lengthy suspension of nine months. This rebound came after the company's notable commitment to creating a debt-restructuring plan aimed at appealing to its...

Continue Reading
Unlocking Long-Term Gains: Insights from Dollar Tree's Success

Updated Category News Views 90

Dollar Tree's Remarkable Growth Over Two Decades Over the last 20 years, Dollar Tree (NASDAQ: DLTR) has become a major player in the retail market, demonstrating incredible resilience and expansion. If someone had put $1,000 into Dollar Tree stock two decades ago, that investment would have surged to more than $7,300 today. This change highlights the effectiveness of...

Continue Reading